Association by guilt: Identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome

BioEssays

Volumn 27, Issue 7, 2005, Pages 676-680

  Bapat, Sharmila ^a   Galande, Sanjeev ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MATRIX ATTACHMENT REGION BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; TRANSCRIPTION FACTOR DLX5; DLX5 PROTEIN, HUMAN; DNA BINDING PROTEIN; HISTONE; HOMEODOMAIN PROTEIN; MECP2 PROTEIN, HUMAN; NONHISTONE PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

CHROMATIN; CHROMOSOME 6Q; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENOME IMPRINTING; HUMAN; MOLECULAR MECHANICS; NONHUMAN; RETT SYNDROME; REVIEW; X CHROMOSOME LINKED DISORDER; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; CPG ISLAND; GENETICS; METABOLISM;

ANIMALS; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; CPG ISLANDS; DNA-BINDING PROTEINS; GENOMIC IMPRINTING; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MODELS, GENETIC; REPRESSOR PROTEINS; RETT SYNDROME; TRANSCRIPTION FACTORS;

EID: 23044466101     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20266     Document Type: Review

References (34)

1. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T. 2005. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 37:31-40.
2. Ausio J, Levin DB, De Amorim GV, Bakker S, Macleod PM. 2003. Syndromes of disordered chromatin remodeling. Clin Genet 64:83-95.
3. Hagberg B. 2002. Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev 8:61-65.
4. Kriaucionis S, Bird A. 2003. DNA methylation and Rett syndrome. Human Molecular Genetics 12:R221-R227.
5. Miltenberger-Miltenyi G, Laccone F. 2003. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum Mutat 22:107-115.
6. Delaval K, Feil R. 2004. Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev 14:188-195.
7. Wade PA. 2001. Methyl CpG-binding proteins and transcriptional repression. Bioessays 23:1131-1137.
8. Ballestar E, Ropero S, Alaminos M, Armstrong J, Setien F, et al. 2005. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum Genet 116:91-104.
9. Kudo S, Nomura Y, Segawa M, Fujita N, Nakao M, et al. 2003. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J Med Genet 40:487-493.
10. Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OL, et al. 2004. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 75:1079-1093.
11. Mnatzakian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, et al. 2004. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 36:339-341.
12. Fukuda T, Yamashita Y, Nagamitsu S, Miyamoto K, Jin JJ, Ohmori I, Ohtsuka Y, Kuwajima K, et al. 2005. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms. Brain Dev 27:211-217.
13. Shahbazian M, Antalffy B, Armstrong DL, Zogbi H. 2002. Insight into Rett syndrome. MECP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11:115-124.
14. Hassan MQ, Javed A, Morasso MI, Karlin J, Montecino M, et al. 2004. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3 and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol 24:9248-9261.
15. Bendall AJ, Hu G, Levi G, Abate-Shen C. 2003. Dlx3 regulates chondrocyte differentiation at multiple stages. Int J Dev Biol 47:335-344.
16. McLarren KW, Litsiou A, Streit A. 2003. Dlx3 positions the neural crest and preplacode region at the border of the neural plate. Dev Biol 259:34-47.
17. Stuhmer T, Anderson SA, Ekker M, Rubenstein JL. 2002. Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development 129:245-252.
18. Perera M, Merlo GR, Verardo S, Paleari L, Corte G, et al. 2004. Defective neuronogenesis in the absence of Dlx3. Mol Cell Neurosci 25:153-161.
19. Levi G, Puche AC, Mantero S, Barbieri O, Trombino S, et al. 2003. The Dlx3 homeodomain gene is essential for olfactory development and connectivity in the mouse. Mol Cell Neurosci 22:530-543.
20. Robledo RF, Rajan L, Li X, Lufkin T. 2002. The Dlx3 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev 16:1089-1101.
21. Peterson CL, Laniel MA. 2004. Histories and histone modifications. Curr Biol 14:R546-R551.
22. Stancheva I, Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR. 2003. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. Mol Cell 12:425-435.
23. Aber KM, Nori P, MacDonald SM, Bibat G, Jarrar MH, et al. 2003. Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions. Neuroscience 116:77-80.
24. Hardingham GE, Arnold FJ, Bading H. 2001. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat Neurosci 4:261-267.
25. Chae JH, Hwang H, Hwang YS, Cheong HJ, Kim KJ. 2004. Influence of MECP2 gene mutation and X-chromosome inactivation on the Rett syndrome phenotype. J Child Neurol 19:503-508.
26. Shahbazian MD, Zoghbi HY. 2002. Rett Syndrome and MeCP2: Linking Epigenetics and Neuronal Function. Am J Hum Genet 71:1259-1272.
27. Balmer D, Arredondo J, Samaco RC, LaSaIIe JM. 2002. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet 110:545-552.
28. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, et al. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393:386-389.
29. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, et al. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19:187-191.
30. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, et al. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278:4035-4040.
31. Harikrishna KN, Chow MZ, Baker EK, Pal S, Bassal S, et al. 2005. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 37:254-264.
32. Weitzel JM, Buhrmester H, Stratling WH. 1997. Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding protein MeCP2. Mol Cell Biol 17:5656-5666.
33. Kumar PP, Purbey PK, Ravi DS, Mitra D, Galande S. 2005. Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol Cell Biol 25:1620-1633.
34. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T. 2002. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419:641-645.